Carrillo, Alexia M <br/><br/>
Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells.  [electronic resource] 

 -  Molecular cancer research : MCR  Aug 2015 
 - 1197-205 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3125 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-15-0089  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cisplatin--administration & dosage<br/>Comet Assay<br/>DNA Breaks, Double-Stranded--drug effects<br/>DNA Damage<br/>DNA Repair<br/>Etoposide--administration & dosage<br/>Female<br/>Fibroblasts--metabolism<br/>HEK293 Cells<br/>Humans<br/>Imidazoles--administration & dosage<br/>Mice<br/>Mice, Transgenic<br/>Mutagens<br/>Ovarian Neoplasms--genetics<br/>Piperazines--administration & dosage<br/>Proto-Oncogene Proteins c-mdm2--genetics<br/>Tumor Suppressor Protein p53--genetics